Frontiers in Pharmacology | Gastrointestinal and Hepatic Pharmacology

Original Research

Published on 01 Feb 2024

Chishao (Paeoniae Radix Rubra) alleviates intra-hepatic cholestasis by modulating NTCP in rats

in Gastrointestinal and Hepatic Pharmacology

Xiaoqi Sun
Jing Fang
Nanyuan Fang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1341651

1,694 views
4 citations

Original Research

Published on 01 Feb 2024

Sesamin ameliorates nonalcoholic steatohepatitis through inhibiting hepatocyte pyroptosis in vivo and in vitro

in Gastrointestinal and Hepatic Pharmacology

Teng Zhang
Yong Zhou
Yan Zhang
De-Guo Wang
Qiu-Yue Lv
Wen Wang
Ya-Ping Bai
Qiang Hua
Li-Qun Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1347274

2,004 views
3 citations

Editorial

Published on 15 Jan 2024

Editorial: Advances in novel drugs and targets for hepatic and gastrointestinal diseases

in Gastrointestinal and Hepatic Pharmacology

Ebenezeri Erasto Ngowi
Yong Gao
Xiaoying Yang
Aijun Qiao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1364290

1,145 views

Original Research

Published on 11 Jan 2024

Utilizing multimodal mass spectrometry imaging for profiling immune cell composition and N-glycosylation across colorectal carcinoma disease progression

in Gastrointestinal and Hepatic Pharmacology

Lyndsay E. A. Young
Paul J. Nietert
Rachel Stubler
Caroline G. Kittrell
Grace Grimsley
David N. Lewin
Anand S. Mehta
Chadi Hajar
Katherine Wang
Elizabeth C. O’Quinn

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1337319

3,845 views
8 citations

Systematic Review

Published on 11 Jan 2024

Comparative efficiency and safety of potassium competitive acid blockers versus Lansoprazole in peptic ulcer: a systematic review and meta-analysis

in Gastrointestinal and Hepatic Pharmacology

Yongqi Dong
Hongyan Xu
Zhihuan Zhang
Zhihang Zhou
Qiang Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1304552

6,033 views
9 citations

Systematic Review

Published on 10 Jan 2024

A bibliometric and visual analysis of the use of ustekinumab in Crohn’s disease using CiteSpace

in Gastrointestinal and Hepatic Pharmacology

Yi Chen
Jiaqi Zhang
Junling Wu
Hanwen Zhang
Zhe Luan
Zhizhuang Zhao
Congyong Li
Yiming Zhao
Hu Zhang
Shufang Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1322319

3,550 views
4 citations

Original Research

Published on 09 Jan 2024

Dimethyloxalylglycine pretreatment of living donor alleviates both donor and graft liver ischemia-reperfusion injury in rats

in Gastrointestinal and Hepatic Pharmacology

Degong Jia
Minjie Zhao
Jiefu Luo
Shengwei Li
Jianping Gong
Mingxiang Cheng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1341575

1,464 views

Editorial

Published on 08 Jan 2024

Editorial: Women in gastrointestinal and hepatic pharmacology 2022

in Gastrointestinal and Hepatic Pharmacology

Eleonora Lai
Jessica Williams
Raquel Abalo
Daniela Gabbia

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1359135

927 views

Systematic Review

Published on 08 Jan 2024

Intestinal microbiome-targeted therapies improve liver function in alcohol-related liver disease by restoring bifidobacteria: a systematic review and meta-analysis

in Gastrointestinal and Hepatic Pharmacology

Xin Chi
Xiu Sun
Danying Cheng
Shunai Liu
Calvin Q. Pan
Huichun Xing

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1274261

2,067 views
1 citation

Original Research

Published on 05 Jan 2024

Role of symbiotic microbiota dysbiosis in the progression of chronic kidney disease accompanied with vascular calcification

in Gastrointestinal and Hepatic Pharmacology

Mengying Sun
Yilong Fang
Jianhua Zheng
Guojuan Shi
Junli Guo
Xinzhou Zhang
Rui Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1306125

3,680 views
4 citations

Original Research

Published on 04 Jan 2024

Unlocking the hepatoprotective potential of the parasitic plant Orobanche foetida Poir. aqueous extract against CCl4-induced liver injury in rat

in Gastrointestinal and Hepatic Pharmacology

Arij Bedoui
Afoua Mufti
Anouar Feriani
Hanene Baccari
Amal Bouallegue
Mohamed Kharrat
Mansour Sobeh
Moez Amri
Zouhaier Abbes

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1320062

3,219 views
4 citations

Original Research

Published on 21 Dec 2023

Serum metabolomics characteristics and fatty-acid-related mechanism of cirrhosis with histological response in chronic hepatitis B

in Gastrointestinal and Hepatic Pharmacology

Hai-Na Fan
Zhi-Min Zhao
Kai Huang
Xiao-Ning Wang
Yun-Kai Dai
Cheng-Hai Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1329266

2,393 views
3 citations

Review

Published on 15 Dec 2023

Macrophage cytotherapy on liver cirrhosis

in Gastrointestinal and Hepatic Pharmacology

Dabing Ping
Yuan Peng
Xudong Hu
Chenghai Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1265935

5,832 views
2 citations

Systematic Review

Published on 13 Dec 2023

Effect of potassium-competitive acid blockers on human gut microbiota: a systematic review and meta-analysis

in Gastrointestinal and Hepatic Pharmacology

Meng-Ling Ouyang
Shu-Peng Zou
Qian Cheng
Xuan Shi
Ya-Zheng Zhao
Ming-Hui Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1269125

2,605 views
4 citations

Review

Published on 12 Dec 2023

Research progress of traditional Chinese medicine in improving hepatic fibrosis based on inhibiting pathological angiogenesis

in Gastrointestinal and Hepatic Pharmacology

Zhen Li
Junfeng Zhu
Hao Ouyang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1303012

3,429 views
8 citations

Original Research

Published on 08 Dec 2023

Cholecystectomy is associated with a higher risk of irritable bowel syndrome in the UK Biobank: a prospective cohort study

in Gastrointestinal and Hepatic Pharmacology

Jinyu Zhao
Liang Tian
Bin Xia
Ningning Mi
Qiangsheng He
Man Yang
Danni Wang
Siqing Wu
Zijun Li
Shiyong Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1244563

9,429 views
4 citations